ETFs Holding CALA »    CALA Historical Stock Prices »
CALA News Video: Tue, Nov 14, 2017, 1:17 PM — Tuesday's ETF Movers: IDU, XBI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Calithera Biosciences is a clinical-stage bio-pharmaceutical company focused on discovering and developing small molecule oncology drugs that targets tumor and immune cell metabolism. Co.'s primary product candidate, CB-839, is an internally discovered, oral inhibitor of glutaminase, a critical enzyme in tumor cells. Co.'s other product candidate, INCB001158, also known as CB-1158, is an oral inhibitor of arginase, an enzyme that depletes the amino acid arginine, a main metabolic nutrient for T-cells. Arginase depletes arginine, a nutrient that is critical for the activation and proliferation of the body's cancer-fighting immune cells, such as cytotoxic T-cells and natural killer-cells. Self directed investors in Calithera Biosciences, Inc. will be interested in keeping up with all Calithera Biosciences, Inc. news they can find, both CALA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on CALA. At RediNews, we simplify this task by presenting both CALA news releases originating from Calithera Biosciences, Inc. itself, and CALA news from a variety of media outlets. Visitors can browse this news online and through our CALA RSS news feed.


CALA News — Articles, Videos, & Press Releases

Sum Up The Pieces: IWN Could Be Worth $137
Thursday, May 16, 2019, 8:20 AM — ETF Channel
Peek Under The Hood: IWN Has 11% Upside
Wednesday, April 10, 2019, 8:06 AM — ETF Channel
Calithera (CALA) Initiates Phase I/II Study of Telaglenastat
Wednesday, March 27, 2019, 3:39 PM — Zacks
Noteworthy Monday Option Activity: CALA, CTXS, ADBE
Monday, March 11, 2019, 3:18 PM — Stock Options Channel
Analysts Predict 12% Upside For IWN
Thursday, March 7, 2019, 7:23 AM — ETF Channel
Analysts Anticipate 18% Upside For IWN
Monday, January 21, 2019, 8:43 AM — ETF Channel
Surprising Analyst 12-Month Target For SPSM
Thursday, December 20, 2018, 7:58 AM — ETF Channel
Commit To Purchase Calithera Biosciences At $2.50, Earn 14.9% Annualized Using Options
Friday, December 7, 2018, 1:21 PM — Stock Options Channel
Peek Under The Hood: SPTM Has 17% Upside
Friday, November 16, 2018, 7:50 AM — ETF Channel
Sum Up The Parts: IWV Could Be Worth $187
Tuesday, October 16, 2018, 7:50 AM — ETF Channel
Calithera Biosciences Breaks Above 200-Day Moving Average - Bullish for CALA
Thursday, October 11, 2018, 3:14 PM — Market News Video
The Implied Analyst 12-Month Target For EQWS
Tuesday, September 11, 2018, 9:05 AM — ETF Channel
Commit To Buy Calithera Biosciences At $5, Earn 17.3% Annualized Using Options
Thursday, September 6, 2018, 11:56 AM — Stock Options Channel
Analysts See 22% Upside For IBB
Monday, August 6, 2018, 8:33 AM — ETF Channel
Short Interest In Calithera Biosciences Moves 32% Lower
Thursday, July 12, 2018, 11:47 AM — Market News Video
Calithera Biosciences Enters Oversold Territory (CALA)
Wednesday, July 11, 2018, 4:17 PM — Dividend Channel
Analysts Expect IBB To Hit $139
Tuesday, July 3, 2018, 8:08 AM — ETF Channel
Commit To Purchase Calithera Biosciences At $5, Earn 57.5% Annualized Using Options
Tuesday, June 5, 2018, 11:51 AM — Stock Options Channel
CALA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites financial news content websites to integrate our XML content for web sites by integrating our RSS feeds found throughout our website wherever news and stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic content is ideal for any financial portal or web portal, from business content web sites to corporate portal intranets. Let RediNews be your content provider of free financial content for news, perfect for location on stock market chart pages by symbol, adding another element of dynamic stock market content to your financial portal. If your web page content already includes elements like SEC filings, screener pages, historical chart information, and other cobranded financial web content, then headlines from RediNews can supplement this dynamic financial content meaningfully.

CALA News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.